Procalcitonin Improves the Glasgow Prognostic Score for Outcome Prediction in Emergency Patients with Cancer: A Cohort Study

Table 3

Association of GPS and mortality overall and in subgroups.

Population	GPS score	OR (95% CI),	AUC (95% CI)	for heterogeneity
Overall	1 point	1.5 (0.5 to 4.8),	0.67 (0.62 to 0.72)
	2 points	6.4 (2.5 to 16.6),
Age specific
<60 years	1 point	0.4 (0 to 4.3),	0.66 (0.53 to 0.80)	<0.001
	2 points	3.4 (0.9 to 13.6),
≥60 years	1 point	2.8 (0.6 to 14.4),	0.66 (0.61 to 0.71)
	2 points	10.1 (2.3 to 43.3),
Cancer type specific
All solid cancers	1 point	1.6 (0.5 to 5.2),	0.66 (0.61 to 0.72)	0.99
	2 points	5.7 (2.2 to 15.1),
GI tract cancer	1 point	0.6 (0 to 11.5),	0.68 (0.59 to 0.76)
	2 points	6.7 (0.8 to 55.7),
Other than GI tract cancer	1 point	1.8 (0.5 to 6.6),	0.67 (0.60 to 0.73)
	2 points	6.1 (2.1 to 17.9),
Respiratory tract tumour	1 point	1.2 (0.1 to 16.2),	0.60 (0.51 to 0.69)
	2 points	3.8 (0.4 to 33.5),
Diagnosis at ED admission
Infection	1 point	1.5 (0.4 to 6.2),	0.63 (0.57 to 0.70)	0.34
	2 points	4.7 (1.3 to 16.3),
No infection	1 point	0.7 (0.1 to 8.4),	0.72 (0.64 to 0.80)
	2 points	8.4 (1.9 to 38.2),
Cardiovascular	1 point	2.1 (0.2 to 28),	0.58 (0.32 to 0.85)
	2 points	1.9 (0.2 to 15.5),
Main symptom at ED admission
Worsening of general condition	1 point	3 (0.3 to 35.3),	0.61 (0.49 to 0.73)	0.25
	2 points	5.3 (0.6 to 46.8),
Pain	1 point	0.7 (0.1 to 5.4),	0.42 (0.22 to 0.62)
	2 points	0.4 (0.1 to 3.1),
Neurologic symptoms	1 point	1.9 (0.1 to 24.9),	0.73 (0.54 to 0.93)
	2 points	8.2 (1.3 to 52),

GI tract: gastrointestinal tract.